Creative Biolabs: Exclusive Liposome Products for Liposomal Drug Development
New York, USA – September 22, 2023 – Liposomes are known for their unique capabilities in the delivery of drugs, improving the therapeutic index of the drug formula, and minimizing adverse effects. Creative Biolabs’ cutting-edge range of liposome products, including but not limited to clodronate liposomes, immunoliposomes, cationic liposomes, and liposomal doxorubicin, offers researchers and pharmaceutical companies improved, efficient resources to assist in accelerated drug formulation and delivery.
The chief scientific officer of R&D at Creative Biolabs said, “We’re excited at the prospect of the new liposome products. By providing these unique liposomes as tools, we hope to accelerate the process of liposomal drug development. Our team is committed to assisting researchers and pharmaceutical companies in achieving their goals more efficiently by using these innovative products.”
A suite of liposome products at Creative Biolabs is highlighted below for reference.
* Clodronate Liposome, a critical component in the development of drugs aimed at diseases affecting the immune system. By exploiting macrophages, these liposomes serve as an efficient tool for curing a variety of conditions, including cancer, infectious diseases, cardiovascular diseases, and more.
* Immunoliposomes: this liposome product encapsulates FDA-approved Doxorubicin, a widely applied anthracycline drug used to treat different types of cancer. The liposome shell gives the drug an increased half-life and reduces cardiotoxicity, converting it into a safer yet powerfully efficient treatment.
* Cationic Liposome
Creative Biolabs provides various high-quality cationic liposome product formulations containing different lipid compositions and cationic lipid species for your research, significantly increasing gene transfection efficiency and paving the path for the development of genetic therapies.
* Liposomal Doxorubicin
Diverse liposomal doxorubicins that are suitable for conjugation of various antibodies, proteins, peptides, and ligands are available at Creative Biolabs for researchers’ specific demands.
Creative Biolabs, with its rigorous standards for quality and ground-breaking research tools, already stands as a recognized leader in the arena of pharmaceutical and biotechnology services. With this latest range of liposome products, researchers and pharmaceutical companies are expected to make an impactful stride toward the advancement of liposomal drug discovery and development.
Explore more information about liposome products at Creative Biolabs, please visit https://www.creative-biolabs.com/lipid-based-delivery.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/lipid-based-delivery
